ACET Q1 2019 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$3M100.0% margin

Operating Income

-$4M-157.8% margin

Net Income

-$4M-149.2% margin

EPS (Diluted)

$-3.52

QoQ Revenue Growth

+100.6%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$251,000

Balance Sheet

Total Assets

$145M

Total Liabilities

$5M

Stockholders' Equity

$5M

Cash & Equivalents

-$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$3M	$0	—
Operating Income	-$4M	-$10M	+57.2%
Net Income	-$4M	-$10M	+58.1%